跳到主要內容
:::

黃祥富 醫師

頭頸部腫瘤腫瘤外科手術、口腔癌手術、鼻咽癌診斷,治療、喉癌,下咽癌診斷與外科治療

教職 : 教授

醫師網路掛號

※直接點選進入醫師網路掛號畫面※

語言

  • 國語,英語,閩南語

現職

  • 長庚醫院耳鼻喉部頭頸腫瘤外科主治醫師
  • 長庚大學教授
  • 長庚醫院教授

學歷

  • 長庚大學臨研所博士
  • 長庚大學醫學系

經歷

  • 長庚醫院林口長庚醫院耳鼻喉部總醫師
  • 台灣耳鼻喉頭頸外科專科醫師
  • 美國耳鼻喉頭頸外科學院(AAOHNS)
  • 美國癌症研究協會(AACR)會員

論文及期刊發表

  • Sequential alterations of Stensen's duct and parotid gland after radical surgeries in buccal cancer.
  • Parapharyngeal space tumors: a serial case study.
  • Amplification of the EGFR and CCND1 Are Coordinated and Play Important Roles in the Progression of Oral Squamous Cell Carcinomas.
  • Alcohol-metabolizing Enzymes' Gene Polymorphisms and Susceptibility to Multiple Head and Neck Cancers.
  • Prognostic Roles of SCC Antigen, CRP and CYFRA 21-1 in Oral Cavity Squamous Cell Carcinoma.
  • Polymorphisms of Mismatch Repair Pathway Genes Predict Clinical Outcomes in Oral Squamous Cell Carcinoma Patients Receiving Adjuvant Concurrent Chemoradiotherapy.
  • Nasopharyngeal carcinoma with mastoid recurrence after concurrent chemoradiotherapy masquerading as acute otomastoiditis.
  • Postoperative radiotherapy with or without concurrent chemotherapy for oral squamous cell carcinoma in patients with three or more minor risk factors: a propensity score matching analysis.
  • Familial aggregation of nasopharyngeal carcinoma in Taiwan.
  • Clinical Outcomes in pT4 Tongue Carcinoma are Worse than in pT3 Disease: How Extrinsic Muscle Invasion Should be Considered?
  • Clinical impact of PET/CT imaging after adjuvant therapy in patients with oral cavity squamous cell carcinoma.
  • EGFR copy number alterations in primary tumors, metastatic lymph nodes, and recurrent and multiple primary tumors in oral cavity squamous cell carcinoma.
  • Body image in head and neck cancer patients treated with radiotherapy: the impact of surgical procedures.
  • Epidermal growth factor receptor intron-1 CA repeat polymorphism on protein expression and clinical outcome in Taiwanese oral squamous cell carcinoma.
  • Epidermal growth factor receptor intron-1 CA repeat polymorphism on protein expression and clinical outcome in Taiwanese oral squamous cell carcinoma.
  • Molecular and serologic markers of HPV 16 infection are associated with local recurrence in patients with oral cavity squamous cell carcinoma.
  • Comparative clinical outcomes of Taiwanese patients with resected buccal and tongue squamous cell carcinomas.
  • Caspase 12 degrades IκBα protein and enhances MMP-9 expression in human nasopharyngeal carcinoma cell invasion.
  • Induction chemotherapy with dose-modified docetaxel, cisplatin, and 5-fluorouracil in Asian patients with borderline resectable or unresectable head and neck cancer.
  • The second-time flap from the previously used anterior thigh donor site for head and neck microsurgical reconstruction.
  • Clinical Outcomes of Taiwanese Patients with cT4 Oral Cavity Squamous Cell Carcinoma: Toward the Identification of the Optimal Initial Treatment Approach for cT4b Patients.
  • Roles of preoperative C-reactive protein are more relevant in buccal cancer than other subsites.
  • An elective radiation dose of 46 Gy is feasible in nasopharyngeal carcinoma treated by intensity-modulated radiotherapy: A long-term follow-up result.
  • Refinements in flap design and inset for pharyngoesophageal reconstruction with free thigh flaps.
  • Local Rhomboid Flap Reconstruction for Skin Defects After Excising Large Parotid Gland Tumors.
  • Preservation of epithelial progenitor cells from collagenase-digested oral mucosa during ex vivo cultivation.
  • Association between the diagnosis-to-treatment interval and overall survival in Taiwanese patients with oral cavity squamous cell carcinoma.
  • Clinical Implications of FADD Gene Amplification and Protein Overexpression in Taiwanese Oral Cavity Squamous Cell Carcinomas.
  • Interplay of N-Cadherin and matrix metalloproteinase 9 enhances human nasopharyngeal carcinoma cell invasion.
  • Blockade of Inhibitors of Apoptosis Proteins in Combination with Conventional Chemotherapy Leads to Synergistic Antitumor Activity in Medulloblastoma and Cancer Stem-Like Cells.
  • Incidence and Outcomes of Patients With Oral Cavity Squamous Cell Carcinoma and Fourth Primary Tumors: A Long-term Follow-up Study in a Betel Quid Chewing Endemic Area.
  • An Ultra-Deep Targeted Sequencing Gene Panel Improves the Prognostic Stratification of Patients With Advanced Oral Cavity Squamous Cell Carcinoma.
  • Association between multidisciplinary team care approach and survival rates in patients with oral cavity squamous cell carcinoma.
  • Pretreatment Dynamic Contrast-Enhanced MRI Improves Prediction of Early Distant Metastases in Patients With Nasopharyngeal Carcinoma.
  • Preoperative SCC Antigen, CRP Serum Levels, and Lymph Node Density in Oral Squamous Cell Carcinoma.
  • Human Papillomavirus Infections are Common and Predict Mortality in a Retrospective Cohort Study of Taiwanese Patients With Oral Cavity Cancer.
  • Clinical Outcomes of Patients with Resected Oral Cavity Cancer and Simultaneous Second Primary Malignancies.
  • Serum markers of CYFRA 21-1 and C-reactive proteins in oral squamous cell carcinoma.
  • The effect of primary cancer cell culture models on the results of drug chemosensitivity assays: the application of perfusion microbioreactor system as cell culture vessel.
  • The role of elective neck dissection in early stage buccal cancer.
  • Positive clinical impact of an additional PET/CT scan before adjuvant radiotherapy or concurrent chemoradiotherapy in patients with advanced oral cavity squamous cell carcinoma.
  • Human papillomavirus 16/18 E7 viral loads predict distant metastasis in oral cavity squamous cell carcinoma.
  • OncomiR-196 promotes an invasive phenotype in oral cancer through the NME4-JNK-TIMP1-MMP signaling pathway.
  • Clinical evidence of field cancerization in patients with oral cavity cancer in a betel quid chewing area.
  • Using SCC antigen and CRP levels as prognostic biomarkers in recurrent oral cavity squamous cell carcinoma.
  • Concurrent chemoradiotherapy using cisplatin, tegafur, and leucovorin for advanced squamous cell carcinoma of the hypopharynx and oropharynx.
  • Prognostic value of prepontine cistern invasion in nasopharyngeal carcinoma treated by intensity-modulated radiotherapy.
  • Postoperative concomitant chemoradiotherapy improved treatment outcomes of patients with oral cavity cancer with multiple-node metastases but no other major risk factors.
  • Dynamic contrast-enhanced MR imaging predicts local control in oropharyngeal or hypopharyngeal squamous cell carcinoma treated with chemoradiotherapy.
  • Increasing rates of low-risk human papillomavirus infections in patients with oral cavity squamous cell carcinoma: Association with clinical outcomes.
  • Clinical significance in oral cavity squamous cell carcinoma of pathogenic somatic mitochondrial mutations.
  • Clinical significance in oral cavity squamous cell carcinoma of pathogenic somatic mitochondrial mutations.
  • Clinical scenario of EBV DNA follow-up in patients of treated localized nasopharyngeal carcinoma.
  • Refining the role of preoperative C-reactive protein by neutrophil/lymphocyte ratio in oral cavity squamous cell carcinoma.
  • Radiology quiz case 1. Common carotid artery mycotic pseudoaneurysm.
  • Risk stratification in oral cavity squamous cell carcinoma by preoperative CRP and SCC antigen levels.
  • Cyclin D1 overexpression and poor clinical outcomes in Taiwanese oral cavity squamous cell carcinoma.